Parathyroid surgery may lower blood pressure hormone, study hopes to find out

NCT ID NCT07388914

Not yet recruiting Knowledge-focused Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 400 adults with primary hyperparathyroidism who are scheduled for parathyroid surgery. Researchers will measure aldosterone, a hormone that helps control blood pressure, before surgery and at 3, 6, and 12 months after. They will also track blood pressure and use of blood pressure medications. The goal is to understand how surgery affects these levels and whether it can improve blood pressure control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could clarify how parathyroid surgery affects blood pressure and hormone levels, potentially guiding future treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to any direct medical changes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY HYPERPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder Parathyroid Neoplasms primary hyperparathyroidism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM DUE TO ADENOMA

Contacts and locations

Locations

Centre Hospitalier Universitaire de Nancy

Nancy, Lorraine, 54000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.